Annual Income Statements for Bain Capital Specialty Finance
This table shows Bain Capital Specialty Finance's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.
Quarterly Income Statements for Bain Capital Specialty Finance
This table shows Bain Capital Specialty Finance's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.
Metric |
|
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Net Income / (Loss) Attributable to Common Shareholders |
|
62 |
-5.27 |
29 |
-38 |
-9.91 |
35 |
29 |
33 |
22 |
-34 |
24 |
Consolidated Net Income / (Loss) |
|
74 |
-5.27 |
37 |
-38 |
-18 |
39 |
28 |
31 |
34 |
-34 |
19 |
Net Income / (Loss) Continuing Operations |
|
65 |
-5.27 |
37 |
-38 |
-18 |
39 |
28 |
31 |
34 |
-34 |
19 |
Total Pre-Tax Income |
|
65 |
-5.27 |
37 |
-38 |
-18 |
39 |
28 |
31 |
34 |
-34 |
19 |
Total Revenue |
|
101 |
-2.85 |
53 |
-34 |
-28 |
62 |
49 |
52 |
53 |
-31 |
37 |
Net Interest Income / (Expense) |
|
103 |
-20 |
38 |
-21 |
-77 |
38 |
37 |
37 |
35 |
-19 |
32 |
Total Interest Income |
|
130 |
0.00 |
58 |
0.00 |
-58 |
56 |
55 |
55 |
56 |
0.00 |
54 |
Investment Securities Interest Income |
|
- |
- |
58 |
- |
- |
56 |
55 |
55 |
56 |
- |
54 |
Total Interest Expense |
|
27 |
20 |
20 |
21 |
19 |
18 |
18 |
18 |
21 |
19 |
22 |
Long-Term Debt Interest Expense |
|
- |
20 |
20 |
21 |
19 |
18 |
18 |
18 |
21 |
19 |
22 |
Total Non-Interest Income |
|
-1.99 |
17 |
16 |
-14 |
49 |
24 |
12 |
14 |
18 |
-12 |
5.02 |
Other Service Charges |
|
2.61 |
5.25 |
1.92 |
1.01 |
2.38 |
5.26 |
3.14 |
5.70 |
4.50 |
2.88 |
4.16 |
Net Realized & Unrealized Capital Gains on Investments |
|
-36 |
11 |
-2.03 |
-15 |
62 |
5.17 |
-5.45 |
-2.89 |
0.47 |
-15 |
-12 |
Other Non-Interest Income |
|
- |
- |
16 |
- |
- |
14 |
14 |
11 |
13 |
- |
13 |
Total Non-Interest Expense |
|
34 |
2.41 |
16 |
3.18 |
-11 |
22 |
22 |
20 |
19 |
3.46 |
19 |
Insurance Policy Acquisition Costs |
|
- |
- |
4.01 |
- |
- |
9.23 |
7.92 |
7.02 |
4.70 |
- |
5.45 |
Other Operating Expenses |
|
30 |
2.41 |
12 |
3.18 |
-6.67 |
13 |
14 |
13 |
14 |
3.46 |
13 |
Basic Earnings per Share |
|
$0.67 |
$0.45 |
$0.45 |
$0.52 |
$0.49 |
$0.55 |
$0.45 |
$0.51 |
$0.34 |
$0.44 |
$0.37 |
Weighted Average Basic Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.68M |
64.87M |
Diluted Earnings per Share |
|
- |
$0.45 |
$0.45 |
$0.52 |
$0.49 |
$0.55 |
$0.45 |
$0.51 |
$0.34 |
$0.44 |
$0.37 |
Weighted Average Diluted Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.68M |
64.87M |
Basic & Diluted Earnings per Share |
|
- |
- |
- |
- |
- |
- |
$0.51 |
- |
- |
- |
$0.47 |
Weighted Average Basic & Diluted Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.61M |
64.87M |
64.87M |
Annual Cash Flow Statements for Bain Capital Specialty Finance
This table details how cash moves in and out of Bain Capital Specialty Finance's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.
Metric |
|
2020 |
2021 |
2022 |
2023 |
2024 |
Net Change in Cash & Equivalents |
|
13 |
127 |
-79 |
-12 |
-13 |
Net Cash From Operating Activities |
|
89 |
266 |
-317 |
219 |
-27 |
Net Cash From Continuing Operating Activities |
|
89 |
266 |
-317 |
218 |
-27 |
Net Income / (Loss) Continuing Operations |
|
8.28 |
120 |
105 |
123 |
119 |
Consolidated Net Income / (Loss) |
|
8.28 |
120 |
105 |
123 |
119 |
Amortization Expense |
|
-3.23 |
0.06 |
-1.04 |
-1.76 |
-1.13 |
Non-Cash Adjustments to Reconcile Net Income |
|
78 |
167 |
-393 |
110 |
-125 |
Changes in Operating Assets and Liabilities, net |
|
-22 |
-21 |
-28 |
-14 |
-21 |
Net Cash From Investing Activities |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Net Cash From Continuing Investing Activities |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Net Cash From Financing Activities |
|
-77 |
-139 |
238 |
-231 |
14 |
Net Cash From Continuing Financing Activities |
|
-77 |
-139 |
238 |
-231 |
14 |
Issuance of Debt |
|
597 |
1,425 |
793 |
348 |
867 |
Repayment of Debt |
|
-716 |
-1,476 |
-467 |
-480 |
-738 |
Payment of Dividends |
|
-86 |
-88 |
-88 |
-99 |
-114 |
Cash Interest Paid |
|
68 |
47 |
43 |
75 |
70 |
Cash Income Taxes Paid |
|
0.00 |
0.24 |
0.13 |
1.22 |
2.25 |
Quarterly Cash Flow Statements for Bain Capital Specialty Finance
This table details how cash moves in and out of Bain Capital Specialty Finance's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.
Metric |
|
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Net Change in Cash & Equivalents |
|
66 |
-44 |
48 |
-22 |
6.57 |
10 |
-24 |
-39 |
40 |
-5.29 |
78 |
Net Cash From Operating Activities |
|
63 |
-43 |
-8.77 |
122 |
149 |
-64 |
192 |
-136 |
-20 |
-7.27 |
0.65 |
Net Cash From Continuing Operating Activities |
|
63 |
-43 |
-8.77 |
122 |
148 |
-64 |
193 |
-136 |
-20 |
-7.27 |
0.65 |
Net Income / (Loss) Continuing Operations |
|
44 |
29 |
29 |
34 |
31 |
35 |
29 |
33 |
22 |
29 |
24 |
Consolidated Net Income / (Loss) |
|
44 |
29 |
29 |
34 |
31 |
35 |
29 |
33 |
22 |
29 |
24 |
Amortization Expense |
|
-0.30 |
-0.90 |
-0.49 |
-0.37 |
-0.01 |
-0.58 |
-0.09 |
-0.03 |
-0.43 |
-0.41 |
0.05 |
Non-Cash Adjustments to Reconcile Net Income |
|
36 |
-72 |
-27 |
90 |
119 |
-102 |
174 |
-161 |
-34 |
-49 |
-6.65 |
Changes in Operating Assets and Liabilities, net |
|
-16 |
0.63 |
-10 |
-1.09 |
-2.76 |
3.49 |
-11 |
-7.48 |
-7.87 |
14 |
-16 |
Net Cash From Financing Activities |
|
2.79 |
-1.24 |
56 |
-145 |
-142 |
74 |
-217 |
97 |
60 |
1.98 |
78 |
Net Cash From Continuing Financing Activities |
|
2.79 |
-1.24 |
56 |
-145 |
-142 |
74 |
-217 |
97 |
60 |
1.98 |
78 |
Issuance of Debt |
|
65 |
155 |
153 |
20 |
20 |
198 |
99 |
268 |
302 |
459 |
300 |
Repayment of Debt |
|
-40 |
-133 |
-72 |
-140 |
-135 |
-97 |
-286 |
-142 |
-213 |
-404 |
-193 |
Payment of Dividends |
|
-22 |
-23 |
-25 |
-25 |
-27 |
-27 |
-29 |
-29 |
-29 |
-58 |
-29 |
Cash Interest Paid |
|
13 |
17 |
18 |
21 |
20 |
18 |
18 |
16 |
19 |
20 |
18 |
Annual Balance Sheets for Bain Capital Specialty Finance
This table presents Bain Capital Specialty Finance's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.
Metric |
2021 |
2022 |
2023 |
2024 |
Total Assets |
2,571 |
2,592 |
2,472 |
2,632 |
Cash and Due from Banks |
117 |
30 |
43 |
52 |
Restricted Cash |
86 |
66 |
63 |
46 |
Trading Account Securities |
5.32 |
0.06 |
0.00 |
2,436 |
Loans and Leases, Net of Allowance |
0.00 |
0.00 |
0.00 |
0.00 |
Other Assets |
77 |
100 |
2,351 |
83 |
Total Liabilities & Shareholders' Equity |
2,571 |
2,592 |
2,472 |
2,632 |
Total Liabilities |
1,471 |
1,476 |
1,336 |
1,492 |
Accrued Interest Payable |
7.06 |
12 |
13 |
14 |
Other Short-Term Payables |
- |
- |
- |
15 |
Long-Term Debt |
1,415 |
1,385 |
1,256 |
1,390 |
Other Long-Term Liabilities |
49 |
79 |
48 |
60 |
Commitments & Contingencies |
0.00 |
0.00 |
0.00 |
0.00 |
Total Equity & Noncontrolling Interests |
1,100 |
1,116 |
1,136 |
1,140 |
Total Preferred & Common Equity |
1,100 |
1,116 |
1,136 |
1,140 |
Total Common Equity |
1,168 |
1,116 |
1,136 |
1,140 |
Common Stock |
1,168 |
1,168 |
1,168 |
1,160 |
Retained Earnings |
- |
-52 |
-32 |
-20 |
Quarterly Balance Sheets for Bain Capital Specialty Finance
This table presents Bain Capital Specialty Finance's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.
Metric |
|
Q3 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q1 2025 |
Q2 2025 |
Total Assets |
|
4.53 |
2,606 |
2,675 |
2,566 |
2,580 |
2,415 |
2,544 |
2,642 |
2,774 |
Cash and Due from Banks |
|
- |
23 |
88 |
65 |
47 |
18 |
25 |
10 |
28 |
Restricted Cash |
|
- |
51 |
36 |
26 |
74 |
67 |
29 |
56 |
137 |
Trading Account Securities |
|
- |
1.11 |
0.06 |
5.85 |
0.92 |
0.65 |
- |
1.47 |
0.00 |
Loans and Leases, Net of Allowance |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Deferred Acquisition Cost |
|
- |
3.51 |
3.28 |
3.04 |
2.57 |
5.12 |
4.86 |
4.33 |
4.07 |
Other Assets |
|
4.53 |
125 |
161 |
2,443 |
2,449 |
91 |
77 |
2,509 |
105 |
Total Liabilities & Shareholders' Equity |
|
0.00 |
2,606 |
2,675 |
2,566 |
2,580 |
2,415 |
2,544 |
2,642 |
2,774 |
Total Liabilities |
|
0.00 |
1,485 |
1,550 |
1,434 |
1,438 |
1,272 |
1,397 |
1,498 |
1,635 |
Accrued Interest Payable |
|
- |
14 |
16 |
15 |
13 |
12 |
13 |
12 |
14 |
Long-Term Debt |
|
- |
1,408 |
1,490 |
1,370 |
1,358 |
1,174 |
1,301 |
1,451 |
1,563 |
Other Long-Term Liabilities |
|
- |
63 |
44 |
42 |
49 |
87 |
83 |
25 |
59 |
Commitments & Contingencies |
|
- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Total Equity & Noncontrolling Interests |
|
0.00 |
1,168 |
1,126 |
1,133 |
1,143 |
1,143 |
1,147 |
1,145 |
1,139 |
Total Preferred & Common Equity |
|
0.00 |
1,121 |
1,126 |
1,133 |
1,143 |
1,143 |
1,147 |
1,145 |
1,139 |
Total Common Equity |
|
0.00 |
1,168 |
1,126 |
1,133 |
1,143 |
1,143 |
1,147 |
1,145 |
1,139 |
Common Stock |
|
- |
1,168 |
1,168 |
1,168 |
1,165 |
1,165 |
1,165 |
1,164 |
1,164 |
Retained Earnings |
|
- |
- |
-43 |
-36 |
-23 |
-23 |
-19 |
-20 |
-25 |
Annual Metrics And Ratios for Bain Capital Specialty Finance
This table displays calculated financial ratios and metrics derived from Bain Capital Specialty Finance's official financial filings.
Metric |
|
2020 |
2021 |
2022 |
2023 |
2024 |
Growth Metrics |
|
- |
- |
- |
- |
- |
Revenue Growth |
|
0.00% |
481.63% |
13.00% |
-106.66% |
1,854.77% |
EBITDA Growth |
|
0.00% |
563.96% |
13.26% |
-121.30% |
617.59% |
EBIT Growth |
|
0.00% |
321.00% |
14.31% |
-119.64% |
661.08% |
NOPAT Growth |
|
0.00% |
415.72% |
14.31% |
-113.75% |
901.54% |
Net Income Growth |
|
0.00% |
321.00% |
14.31% |
-119.64% |
661.08% |
EPS Growth |
|
0.00% |
1,228.57% |
-12.37% |
17.18% |
-3.14% |
Operating Cash Flow Growth |
|
0.00% |
196.98% |
-219.31% |
169.21% |
-112.36% |
Free Cash Flow Firm Growth |
|
0.00% |
0.00% |
105.52% |
-30.24% |
-105.97% |
Invested Capital Growth |
|
0.00% |
0.00% |
-0.53% |
-4.37% |
5.75% |
Revenue Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-110.47% |
60.59% |
EBITDA Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-142.75% |
64.46% |
EBIT Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-138.44% |
64.43% |
NOPAT Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-127.93% |
64.43% |
Net Income Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-134.37% |
64.43% |
EPS Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
-7.50% |
Operating Cash Flow Q/Q Growth |
|
0.00% |
0.00% |
-1.95% |
64.08% |
-119.14% |
Free Cash Flow Firm Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
-104.08% |
Invested Capital Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-4.41% |
3.38% |
Profitability Metrics |
|
- |
- |
- |
- |
- |
EBITDA Margin |
|
0.00% |
64.28% |
64.42% |
0.00% |
60.79% |
EBIT Margin |
|
0.00% |
64.24% |
64.99% |
0.00% |
61.31% |
Profit (Net Income) Margin |
|
0.00% |
64.24% |
64.99% |
0.00% |
61.31% |
Tax Burden Percent |
|
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
Interest Burden Percent |
|
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
Effective Tax Rate |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Return on Invested Capital (ROIC) |
|
0.00% |
8.33% |
4.77% |
0.00% |
5.36% |
ROIC Less NNEP Spread (ROIC-NNEP) |
|
0.00% |
8.33% |
4.77% |
0.00% |
5.36% |
Return on Net Nonoperating Assets (RNNOA) |
|
0.00% |
10.72% |
6.03% |
0.00% |
6.24% |
Return on Equity (ROE) |
|
0.00% |
19.05% |
10.81% |
-2.09% |
11.60% |
Cash Return on Invested Capital (CROIC) |
|
0.00% |
-191.67% |
5.30% |
3.79% |
-0.23% |
Operating Return on Assets (OROA) |
|
0.00% |
4.07% |
4.64% |
0.00% |
5.17% |
Return on Assets (ROA) |
|
0.00% |
4.07% |
4.64% |
0.00% |
5.17% |
Return on Common Equity (ROCE) |
|
0.00% |
20.23% |
11.14% |
-2.09% |
11.60% |
Return on Equity Simple (ROE_SIMPLE) |
|
0.00% |
9.52% |
10.73% |
-2.07% |
11.58% |
Net Operating Profit after Tax (NOPAT) |
|
-33 |
105 |
120 |
-16 |
132 |
NOPAT Margin |
|
0.00% |
64.24% |
64.99% |
0.00% |
61.31% |
Net Nonoperating Expense Percent (NNEP) |
|
0.00% |
0.00% |
0.00% |
0.53% |
0.00% |
SG&A Expenses to Revenue |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Operating Expenses to Revenue |
|
0.00% |
35.76% |
35.01% |
0.00% |
38.69% |
Earnings before Interest and Taxes (EBIT) |
|
-47 |
105 |
120 |
-24 |
132 |
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
-23 |
105 |
119 |
-25 |
131 |
Valuation Ratios |
|
- |
- |
- |
- |
- |
Price to Book Value (P/BV) |
|
0.00 |
0.00 |
0.54 |
0.75 |
0.97 |
Price to Tangible Book Value (P/TBV) |
|
0.00 |
0.00 |
0.54 |
0.75 |
0.97 |
Price to Revenue (P/Rev) |
|
0.00 |
0.00 |
3.25 |
0.00 |
5.11 |
Price to Earnings (P/E) |
|
0.00 |
0.00 |
5.68 |
0.00 |
9.22 |
Dividend Yield |
|
18.31% |
12.71% |
14.88% |
12.15% |
8.09% |
Earnings Yield |
|
0.00% |
0.00% |
17.62% |
0.00% |
10.85% |
Enterprise Value to Invested Capital (EV/IC) |
|
0.00 |
0.00 |
0.75 |
0.84 |
0.95 |
Enterprise Value to Revenue (EV/Rev) |
|
0.00 |
0.00 |
10.24 |
0.00 |
11.12 |
Enterprise Value to EBITDA (EV/EBITDA) |
|
0.00 |
0.00 |
15.90 |
0.00 |
18.29 |
Enterprise Value to EBIT (EV/EBIT) |
|
0.00 |
0.00 |
15.76 |
0.00 |
18.13 |
Enterprise Value to NOPAT (EV/NOPAT) |
|
0.00 |
0.00 |
15.76 |
0.00 |
18.13 |
Enterprise Value to Operating Cash Flow (EV/OCF) |
|
0.00 |
0.00 |
0.00 |
9.12 |
0.00 |
Enterprise Value to Free Cash Flow (EV/FCFF) |
|
0.00 |
0.00 |
14.19 |
21.54 |
0.00 |
Leverage & Solvency |
|
- |
- |
- |
- |
- |
Debt to Equity |
|
0.00 |
1.29 |
1.24 |
1.11 |
1.22 |
Long-Term Debt to Equity |
|
0.00 |
1.29 |
1.24 |
1.11 |
1.22 |
Financial Leverage |
|
0.00 |
1.29 |
1.26 |
1.17 |
1.16 |
Leverage Ratio |
|
0.00 |
2.34 |
2.33 |
2.25 |
2.24 |
Compound Leverage Factor |
|
0.00 |
2.34 |
2.33 |
2.25 |
2.24 |
Debt to Total Capital |
|
0.00% |
56.26% |
55.37% |
52.50% |
54.95% |
Short-Term Debt to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Long-Term Debt to Total Capital |
|
0.00% |
56.26% |
55.37% |
52.50% |
54.95% |
Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Noncontrolling Interests to Total Capital |
|
0.00% |
-2.72% |
0.00% |
0.00% |
0.00% |
Common Equity to Total Capital |
|
0.00% |
46.46% |
44.63% |
47.50% |
45.05% |
Debt to EBITDA |
|
0.00 |
13.50 |
11.67 |
-49.67 |
10.62 |
Net Debt to EBITDA |
|
0.00 |
11.56 |
10.86 |
-45.47 |
9.88 |
Long-Term Debt to EBITDA |
|
0.00 |
13.50 |
11.67 |
-49.67 |
10.62 |
Debt to NOPAT |
|
0.00 |
13.51 |
11.57 |
-76.26 |
10.53 |
Net Debt to NOPAT |
|
0.00 |
11.56 |
10.76 |
-69.82 |
9.80 |
Long-Term Debt to NOPAT |
|
0.00 |
13.51 |
11.57 |
-76.26 |
10.53 |
Noncontrolling Interest Sharing Ratio |
|
0.00% |
-6.22% |
-3.09% |
0.00% |
0.00% |
Liquidity Ratios |
|
- |
- |
- |
- |
- |
Cash Flow Metrics |
|
- |
- |
- |
- |
- |
Free Cash Flow to Firm (FCFF) |
|
0.00 |
-2,410 |
133 |
93 |
-5.54 |
Operating Cash Flow to CapEx |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Free Cash Flow to Firm to Interest Expense |
|
0.00 |
-46.94 |
2.54 |
1.16 |
-0.07 |
Operating Cash Flow to Interest Expense |
|
1.41 |
5.17 |
-6.06 |
2.74 |
-0.36 |
Operating Cash Flow Less CapEx to Interest Expense |
|
1.41 |
5.17 |
-6.06 |
2.74 |
-0.36 |
Efficiency Ratios |
|
- |
- |
- |
- |
- |
Asset Turnover |
|
0.00 |
0.06 |
0.07 |
0.00 |
0.08 |
Fixed Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
Invested Capital |
|
0.00 |
2,515 |
2,502 |
2,392 |
2,530 |
Invested Capital Turnover |
|
0.00 |
0.13 |
0.07 |
0.00 |
0.09 |
Increase / (Decrease) in Invested Capital |
|
0.00 |
2,515 |
-13 |
-109 |
138 |
Enterprise Value (EV) |
|
0.00 |
0.00 |
1,888 |
2,000 |
2,394 |
Market Capitalization |
|
0.00 |
0.00 |
599 |
850 |
1,101 |
Book Value per Share |
|
$0.00 |
$18.10 |
$17.29 |
$17.60 |
$17.65 |
Tangible Book Value per Share |
|
$0.00 |
$18.10 |
$17.29 |
$17.60 |
$17.65 |
Total Capital |
|
0.00 |
2,515 |
2,502 |
2,392 |
2,530 |
Total Debt |
|
0.00 |
1,415 |
1,385 |
1,256 |
1,390 |
Total Long-Term Debt |
|
0.00 |
1,415 |
1,385 |
1,256 |
1,390 |
Net Debt |
|
0.00 |
1,211 |
1,289 |
1,150 |
1,293 |
Capital Expenditures (CapEx) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Net Nonoperating Expense (NNE) |
|
14 |
0.00 |
0.00 |
7.06 |
0.00 |
Net Nonoperating Obligations (NNO) |
|
0.00 |
1,415 |
1,385 |
1,256 |
1,390 |
Total Depreciation and Amortization (D&A) |
|
25 |
0.06 |
-1.04 |
-1.76 |
-1.13 |
Earnings Adjustments |
|
- |
- |
- |
- |
- |
Adjusted Basic Earnings per Share |
|
$0.00 |
$0.00 |
$1.63 |
$1.91 |
$1.85 |
Adjusted Weighted Average Basic Shares Outstanding |
|
0.00 |
0.00 |
64.56M |
64.56M |
64.56M |
Adjusted Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$1.63 |
$1.91 |
$1.85 |
Adjusted Weighted Average Diluted Shares Outstanding |
|
0.00 |
0.00 |
64.56M |
64.56M |
64.56M |
Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
0.00 |
0.00 |
64.56M |
64.56M |
64.61M |
Normalized Net Operating Profit after Tax (NOPAT) |
|
-33 |
73 |
84 |
-16 |
92 |
Normalized NOPAT Margin |
|
0.00% |
44.97% |
45.49% |
0.00% |
42.92% |
Pre Tax Income Margin |
|
0.00% |
64.24% |
64.99% |
0.00% |
61.31% |
Debt Service Ratios |
|
- |
- |
- |
- |
- |
EBIT to Interest Expense |
|
-0.75 |
2.04 |
2.29 |
-0.29 |
1.77 |
NOPAT to Interest Expense |
|
-0.52 |
2.04 |
2.29 |
-0.21 |
1.77 |
EBIT Less CapEx to Interest Expense |
|
-0.75 |
2.04 |
2.29 |
-0.29 |
1.77 |
NOPAT Less CapEx to Interest Expense |
|
-0.52 |
2.04 |
2.29 |
-0.21 |
1.77 |
Payout Ratios |
|
- |
- |
- |
- |
- |
Dividend Payout Ratio |
|
-181.94% |
83.81% |
73.32% |
-422.60% |
86.57% |
Augmented Payout Ratio |
|
-181.94% |
83.81% |
73.32% |
-422.60% |
86.57% |
Quarterly Metrics And Ratios for Bain Capital Specialty Finance
This table displays calculated financial ratios and metrics derived from Bain Capital Specialty Finance's official financial filings.
Metric |
|
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Growth Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Revenue Growth |
|
0.00% |
-119.86% |
6.58% |
-282.04% |
-127.99% |
2,261.24% |
-7.60% |
250.07% |
287.08% |
-149.90% |
-23.74% |
EBITDA Growth |
|
0.00% |
-151.19% |
49.83% |
-343.27% |
-126.38% |
725.68% |
-24.26% |
182.02% |
291.05% |
-189.79% |
-31.26% |
EBIT Growth |
|
0.00% |
-141.96% |
50.72% |
-340.19% |
-126.25% |
843.10% |
-25.00% |
182.91% |
293.55% |
-187.43% |
-31.67% |
NOPAT Growth |
|
0.00% |
-129.37% |
38.07% |
-268.14% |
-119.01% |
1,161.57% |
-25.00% |
218.44% |
376.50% |
-161.20% |
-31.67% |
Net Income Growth |
|
0.00% |
-141.96% |
114.09% |
-340.19% |
-123.70% |
843.10% |
-25.00% |
182.91% |
293.55% |
-187.43% |
-31.67% |
EPS Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
22.22% |
0.00% |
-1.92% |
-30.61% |
-20.00% |
-17.78% |
Operating Cash Flow Growth |
|
-8.75% |
57.78% |
95.08% |
222.69% |
135.81% |
-48.26% |
2,293.15% |
-211.07% |
-113.44% |
88.59% |
-99.66% |
Free Cash Flow Firm Growth |
|
0.00% |
0.00% |
0.00% |
-22,845.60% |
0.00% |
102.69% |
112.66% |
103.43% |
-206.68% |
-275.51% |
-212.17% |
Invested Capital Growth |
|
0.00% |
0.00% |
0.00% |
55,210.25% |
-4.37% |
-1.15% |
-11.43% |
-2.22% |
5.75% |
3.82% |
16.63% |
Revenue Q/Q Growth |
|
435.79% |
-102.82% |
1,967.06% |
-164.54% |
17.63% |
317.76% |
-20.17% |
4.81% |
2.68% |
-158.09% |
221.88% |
EBITDA Q/Q Growth |
|
328.84% |
-109.22% |
690.83% |
-204.12% |
53.50% |
318.71% |
-28.48% |
12.76% |
8.32% |
-202.79% |
154.68% |
EBIT Q/Q Growth |
|
329.56% |
-107.84% |
800.59% |
-201.74% |
53.05% |
322.04% |
-29.29% |
12.48% |
9.61% |
-200.30% |
155.18% |
NOPAT Q/Q Growth |
|
315.22% |
-105.68% |
1,100.84% |
-171.22% |
53.05% |
417.20% |
-29.29% |
12.48% |
9.61% |
-170.21% |
178.82% |
Net Income Q/Q Growth |
|
375.93% |
-107.08% |
800.59% |
-201.74% |
53.05% |
322.04% |
-29.29% |
12.48% |
9.61% |
-200.30% |
155.18% |
EPS Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
15.56% |
-5.77% |
12.24% |
-18.18% |
13.33% |
-33.33% |
29.41% |
-15.91% |
Operating Cash Flow Q/Q Growth |
|
163.25% |
-168.13% |
79.58% |
1,494.01% |
21.56% |
-142.83% |
402.14% |
-170.60% |
85.29% |
63.63% |
108.89% |
Free Cash Flow Firm Q/Q Growth |
|
-100.00% |
0.00% |
-1.81% |
2.09% |
103.84% |
-29.74% |
379.39% |
-73.45% |
-219.30% |
-15.58% |
-206.34% |
Invested Capital Q/Q Growth |
|
55,186.06% |
1.10% |
3.41% |
-4.31% |
-4.41% |
4.50% |
-7.34% |
5.64% |
3.38% |
2.60% |
4.08% |
Profitability Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
EBITDA Margin |
|
66.08% |
0.00% |
68.38% |
0.00% |
0.00% |
62.56% |
56.05% |
60.30% |
63.61% |
0.00% |
50.50% |
EBIT Margin |
|
66.38% |
0.00% |
69.30% |
0.00% |
0.00% |
63.50% |
56.24% |
60.35% |
64.42% |
0.00% |
50.36% |
Profit (Net Income) Margin |
|
73.54% |
0.00% |
69.30% |
0.00% |
0.00% |
63.50% |
56.24% |
60.35% |
64.42% |
0.00% |
50.36% |
Tax Burden Percent |
|
114.62% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
Interest Burden Percent |
|
96.66% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
Effective Tax Rate |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Return on Invested Capital (ROIC) |
|
4.73% |
0.00% |
9.03% |
0.00% |
0.00% |
1.32% |
1.10% |
3.27% |
5.64% |
0.00% |
2.23% |
ROIC Less NNEP Spread (ROIC-NNEP) |
|
5.41% |
0.00% |
9.03% |
0.00% |
0.00% |
1.32% |
1.10% |
3.27% |
5.64% |
0.00% |
2.23% |
Return on Net Nonoperating Assets (RNNOA) |
|
6.71% |
0.00% |
11.94% |
0.00% |
0.00% |
1.55% |
1.29% |
3.83% |
6.55% |
0.00% |
2.68% |
Return on Equity (ROE) |
|
11.44% |
0.00% |
20.97% |
0.00% |
-2.09% |
2.87% |
2.39% |
7.10% |
12.19% |
0.00% |
4.91% |
Cash Return on Invested Capital (CROIC) |
|
5.32% |
0.00% |
0.00% |
0.00% |
3.79% |
1.98% |
12.59% |
5.49% |
-0.23% |
-1.45% |
-13.36% |
Operating Return on Assets (OROA) |
|
4.74% |
0.00% |
4.41% |
0.00% |
0.00% |
1.28% |
1.06% |
3.17% |
5.43% |
0.00% |
2.16% |
Return on Assets (ROA) |
|
5.25% |
0.00% |
4.41% |
0.00% |
0.00% |
1.28% |
1.06% |
3.17% |
5.43% |
0.00% |
2.16% |
Return on Common Equity (ROCE) |
|
11.79% |
0.00% |
20.97% |
0.00% |
-2.09% |
2.87% |
2.39% |
7.10% |
12.19% |
0.00% |
4.91% |
Return on Equity Simple (ROE_SIMPLE) |
|
0.00% |
9.09% |
10.80% |
6.04% |
0.00% |
1.83% |
1.02% |
7.00% |
0.00% |
5.13% |
4.38% |
Net Operating Profit after Tax (NOPAT) |
|
65 |
-3.69 |
37 |
-26 |
-12 |
39 |
28 |
31 |
34 |
-24 |
19 |
NOPAT Margin |
|
64.16% |
0.00% |
69.30% |
0.00% |
0.00% |
63.50% |
56.24% |
60.35% |
64.42% |
0.00% |
50.36% |
Net Nonoperating Expense Percent (NNEP) |
|
-0.68% |
0.23% |
0.00% |
1.64% |
0.40% |
0.00% |
0.00% |
0.00% |
0.00% |
0.73% |
0.00% |
SG&A Expenses to Revenue |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Operating Expenses to Revenue |
|
33.62% |
0.00% |
30.70% |
0.00% |
0.00% |
36.50% |
43.76% |
39.65% |
35.58% |
0.00% |
49.64% |
Earnings before Interest and Taxes (EBIT) |
|
67 |
-5.27 |
37 |
-38 |
-18 |
39 |
28 |
31 |
34 |
-34 |
19 |
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
67 |
-6.16 |
36 |
-38 |
-18 |
39 |
28 |
31 |
34 |
-35 |
19 |
Valuation Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Price to Book Value (P/BV) |
|
0.54 |
0.53 |
0.64 |
0.74 |
0.75 |
0.80 |
0.85 |
0.89 |
0.97 |
0.94 |
0.86 |
Price to Tangible Book Value (P/TBV) |
|
0.54 |
0.53 |
0.64 |
0.74 |
0.75 |
0.80 |
0.85 |
0.89 |
0.97 |
0.94 |
0.86 |
Price to Revenue (P/Rev) |
|
3.25 |
3.71 |
4.24 |
7.17 |
0.00 |
17.43 |
20.20 |
7.58 |
5.11 |
8.73 |
8.77 |
Price to Earnings (P/E) |
|
5.68 |
7.06 |
7.09 |
17.26 |
0.00 |
54.06 |
58.06 |
11.63 |
9.22 |
21.40 |
21.80 |
Dividend Yield |
|
14.88% |
14.81% |
13.06% |
11.83% |
12.15% |
8.87% |
8.76% |
8.57% |
8.09% |
11.02% |
14.96% |
Earnings Yield |
|
17.62% |
14.16% |
14.11% |
5.80% |
0.00% |
1.85% |
1.72% |
8.59% |
10.85% |
4.67% |
4.59% |
Enterprise Value to Invested Capital (EV/IC) |
|
0.75 |
0.77 |
0.80 |
0.85 |
0.84 |
0.86 |
0.89 |
0.92 |
0.95 |
0.95 |
0.88 |
Enterprise Value to Revenue (EV/Rev) |
|
10.24 |
11.69 |
12.25 |
18.09 |
0.00 |
41.14 |
42.80 |
16.88 |
11.12 |
20.00 |
21.33 |
Enterprise Value to EBITDA (EV/EBITDA) |
|
15.90 |
19.42 |
18.53 |
35.83 |
0.00 |
110.55 |
194.62 |
28.43 |
18.29 |
42.59 |
48.33 |
Enterprise Value to EBIT (EV/EBIT) |
|
15.76 |
19.15 |
18.25 |
34.63 |
0.00 |
102.93 |
177.10 |
28.18 |
18.13 |
41.89 |
47.54 |
Enterprise Value to NOPAT (EV/NOPAT) |
|
15.76 |
19.15 |
18.62 |
35.94 |
0.00 |
102.93 |
177.10 |
28.18 |
18.13 |
41.89 |
47.54 |
Enterprise Value to Operating Cash Flow (EV/OCF) |
|
0.00 |
0.00 |
0.00 |
15.86 |
9.12 |
10.82 |
5.16 |
15.98 |
0.00 |
83.83 |
0.00 |
Enterprise Value to Free Cash Flow (EV/FCFF) |
|
0.00 |
0.00 |
0.00 |
0.00 |
21.54 |
43.07 |
6.64 |
16.65 |
0.00 |
0.00 |
0.00 |
Leverage & Solvency |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Debt to Equity |
|
1.24 |
1.21 |
1.32 |
1.21 |
1.11 |
1.19 |
1.03 |
1.13 |
1.22 |
1.27 |
1.37 |
Long-Term Debt to Equity |
|
1.24 |
1.21 |
1.32 |
1.21 |
1.11 |
1.19 |
1.03 |
1.13 |
1.22 |
1.27 |
1.37 |
Financial Leverage |
|
1.24 |
1.16 |
1.32 |
1.21 |
1.17 |
1.18 |
1.17 |
1.17 |
1.16 |
1.23 |
1.20 |
Leverage Ratio |
|
2.33 |
2.23 |
2.38 |
2.27 |
2.25 |
2.24 |
2.24 |
2.24 |
2.24 |
2.28 |
2.27 |
Compound Leverage Factor |
|
2.25 |
2.23 |
2.38 |
2.27 |
2.25 |
2.24 |
2.24 |
2.24 |
2.24 |
2.28 |
2.27 |
Debt to Total Capital |
|
55.37% |
54.65% |
56.96% |
54.75% |
52.50% |
54.30% |
50.68% |
53.15% |
54.95% |
55.91% |
57.84% |
Short-Term Debt to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Long-Term Debt to Total Capital |
|
55.37% |
54.65% |
56.96% |
54.75% |
52.50% |
54.30% |
50.68% |
53.15% |
54.95% |
55.91% |
57.84% |
Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Noncontrolling Interests to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Common Equity to Total Capital |
|
44.63% |
45.35% |
43.04% |
45.25% |
47.50% |
45.70% |
49.32% |
46.85% |
45.05% |
44.09% |
42.16% |
Debt to EBITDA |
|
11.67 |
14.01 |
13.23 |
23.16 |
-49.67 |
69.90 |
110.84 |
16.34 |
10.62 |
25.14 |
31.82 |
Net Debt to EBITDA |
|
10.86 |
13.26 |
12.12 |
21.62 |
-45.47 |
63.70 |
102.78 |
15.66 |
9.88 |
24.00 |
28.46 |
Long-Term Debt to EBITDA |
|
11.67 |
14.01 |
13.23 |
23.16 |
-49.67 |
69.90 |
110.84 |
16.34 |
10.62 |
25.14 |
31.82 |
Debt to NOPAT |
|
11.57 |
13.81 |
13.29 |
23.24 |
-76.26 |
65.07 |
100.86 |
16.20 |
10.53 |
24.73 |
31.30 |
Net Debt to NOPAT |
|
10.76 |
13.08 |
12.18 |
21.69 |
-69.82 |
59.31 |
93.52 |
15.52 |
9.80 |
23.61 |
28.00 |
Long-Term Debt to NOPAT |
|
11.57 |
13.81 |
13.29 |
23.24 |
-76.26 |
65.07 |
100.86 |
16.20 |
10.53 |
24.73 |
31.30 |
Noncontrolling Interest Sharing Ratio |
|
-3.09% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Liquidity Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Cash Flow Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Free Cash Flow to Firm (FCFF) |
|
0.00 |
-2,533 |
-2,579 |
-2,525 |
97 |
68 |
327 |
87 |
-103 |
-120 |
-366 |
Operating Cash Flow to CapEx |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Free Cash Flow to Firm to Interest Expense |
|
0.00 |
-129.55 |
-126.03 |
-121.52 |
5.04 |
3.77 |
18.52 |
4.79 |
-4.95 |
-6.32 |
-16.82 |
Operating Cash Flow to Interest Expense |
|
2.31 |
-2.20 |
-0.43 |
5.89 |
7.73 |
-3.53 |
10.91 |
-7.50 |
-0.96 |
-0.38 |
0.03 |
Operating Cash Flow Less CapEx to Interest Expense |
|
2.31 |
-2.20 |
-0.43 |
5.89 |
7.73 |
-3.53 |
10.91 |
-7.50 |
-0.96 |
-0.38 |
0.03 |
Efficiency Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Asset Turnover |
|
0.07 |
0.06 |
0.06 |
0.09 |
0.00 |
0.02 |
0.02 |
0.05 |
0.08 |
0.05 |
0.04 |
Fixed Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Invested Capital |
|
2,502 |
2,529 |
2,615 |
2,503 |
2,392 |
2,500 |
2,316 |
2,447 |
2,530 |
2,596 |
2,702 |
Invested Capital Turnover |
|
0.07 |
0.13 |
0.13 |
0.09 |
0.00 |
0.02 |
0.02 |
0.05 |
0.09 |
0.05 |
0.04 |
Increase / (Decrease) in Invested Capital |
|
0.00 |
2,529 |
2,615 |
2,498 |
-109 |
-29 |
-299 |
-56 |
138 |
96 |
385 |
Enterprise Value (EV) |
|
1,888 |
1,953 |
2,087 |
2,119 |
2,000 |
2,147 |
2,061 |
2,263 |
2,394 |
2,458 |
2,373 |
Market Capitalization |
|
599 |
619 |
722 |
840 |
850 |
910 |
973 |
1,017 |
1,101 |
1,073 |
976 |
Book Value per Share |
|
$17.29 |
$18.10 |
$17.44 |
$17.54 |
$17.60 |
$17.70 |
$17.70 |
$17.76 |
$17.65 |
$17.71 |
$17.56 |
Tangible Book Value per Share |
|
$17.29 |
$18.10 |
$17.44 |
$17.54 |
$17.60 |
$17.70 |
$17.70 |
$17.76 |
$17.65 |
$17.71 |
$17.56 |
Total Capital |
|
2,502 |
2,576 |
2,615 |
2,503 |
2,392 |
2,500 |
2,316 |
2,447 |
2,530 |
2,596 |
2,702 |
Total Debt |
|
1,385 |
1,408 |
1,490 |
1,370 |
1,256 |
1,358 |
1,174 |
1,301 |
1,390 |
1,451 |
1,563 |
Total Long-Term Debt |
|
1,385 |
1,408 |
1,490 |
1,370 |
1,256 |
1,358 |
1,174 |
1,301 |
1,390 |
1,451 |
1,563 |
Net Debt |
|
1,289 |
1,333 |
1,366 |
1,279 |
1,150 |
1,237 |
1,089 |
1,246 |
1,293 |
1,385 |
1,398 |
Capital Expenditures (CapEx) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Net Nonoperating Expense (NNE) |
|
-9.49 |
1.58 |
0.00 |
11 |
5.29 |
0.00 |
0.00 |
0.00 |
0.00 |
10 |
0.00 |
Net Nonoperating Obligations (NNO) |
|
1,385 |
1,361 |
1,490 |
1,370 |
1,256 |
1,358 |
1,174 |
1,301 |
1,390 |
1,451 |
1,563 |
Total Depreciation and Amortization (D&A) |
|
-0.30 |
-0.90 |
-0.49 |
-0.37 |
-0.01 |
-0.58 |
-0.09 |
-0.03 |
-0.43 |
-0.41 |
0.05 |
Earnings Adjustments |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Adjusted Basic Earnings per Share |
|
$0.67 |
$0.45 |
$0.45 |
$0.52 |
$0.49 |
$0.55 |
$0.45 |
$0.51 |
$0.34 |
$0.44 |
$0.37 |
Adjusted Weighted Average Basic Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.68M |
64.87M |
Adjusted Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.49 |
$0.55 |
$0.45 |
$0.51 |
$0.34 |
$0.44 |
$0.37 |
Adjusted Weighted Average Diluted Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.68M |
64.87M |
Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.47 |
Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.61M |
64.87M |
64.87M |
Normalized Net Operating Profit after Tax (NOPAT) |
|
45 |
-3.69 |
26 |
-26 |
-12 |
27 |
19 |
22 |
24 |
-24 |
13 |
Normalized NOPAT Margin |
|
44.91% |
0.00% |
48.51% |
0.00% |
0.00% |
44.45% |
39.37% |
42.25% |
45.10% |
0.00% |
35.25% |
Pre Tax Income Margin |
|
64.16% |
0.00% |
69.30% |
0.00% |
0.00% |
63.50% |
56.24% |
60.35% |
64.42% |
0.00% |
50.36% |
Debt Service Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
EBIT to Interest Expense |
|
2.46 |
-0.27 |
1.80 |
-1.81 |
-0.92 |
2.17 |
1.57 |
1.72 |
1.63 |
-1.81 |
0.87 |
NOPAT to Interest Expense |
|
2.38 |
-0.19 |
1.80 |
-1.26 |
-0.64 |
2.17 |
1.57 |
1.72 |
1.63 |
-1.27 |
0.87 |
EBIT Less CapEx to Interest Expense |
|
2.46 |
-0.27 |
1.80 |
-1.81 |
-0.92 |
2.17 |
1.57 |
1.72 |
1.63 |
-1.81 |
0.87 |
NOPAT Less CapEx to Interest Expense |
|
2.38 |
-0.19 |
1.80 |
-1.26 |
-0.64 |
2.17 |
1.57 |
1.72 |
1.63 |
-1.27 |
0.87 |
Payout Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Dividend Payout Ratio |
|
73.32% |
87.39% |
75.39% |
137.70% |
-422.60% |
495.16% |
926.36% |
139.93% |
86.57% |
247.82% |
291.53% |
Augmented Payout Ratio |
|
73.32% |
87.39% |
75.39% |
137.70% |
-422.60% |
495.16% |
926.36% |
139.93% |
86.57% |
247.82% |
291.53% |
Key Financial Trends
Bain Capital Specialty Finance (NYSE: BCSF) has displayed several notable financial trends over the last four years based on income statements, cash flow, and balance sheet data through Q2 2025.
Positive Factors:
- Consistent positive Net Income with Q2 2025 showing $23.7 million, rebounding from a Q1 2025 loss, indicating improved profitability.
- Total Interest Income remained strong and relatively stable, around $54-58 million in recent quarters, supporting core revenue.
- Net Interest Income has been consistently positive except for some quarters in 2023, with $32.5 million in Q2 2025 showing core operational strength.
- Rising Total Assets from ~$2.4 billion in early 2023 to $2.7 billion by Q2 2025, signaling balance sheet growth and potential for increased income.
- Common Equity has remained strong and stable around $1.1 billion, signaling healthy capitalization.
- Net Cash from Continuing Financing Activities remained positive in recent quarters (e.g., $77.8 million in Q2 2025), indicating good access to capital markets for debt financing.
- Dividends paid consistently, with $29-$58 million paid in recent quarters, indicating a shareholder return focus and confidence in cash flow.
Neutral Factors:
- Amortization Expenses remain low (around $40,000-$500,000), so non-cash charges are not a large drag on earnings.
- Cash and Due from Banks somewhat volatile but generally in the range of $10 million to $28 million in recent quarters, a typical liquidity range for specialty finance firms.
- Changing operating liabilities and assets cause some variability in cash flow from operating activities, reflecting normal fluctuations in receivables and payables.
Negative Factors:
- Significant volatility in Non-Interest Income, with net realized and unrealized losses up to $11 million in Q2 2025 detracting from overall revenue.
- Large swings in Net Cash from Operating Activities, including negative -$135 million in Q3 2024 and positive $192 million in Q2 2024, indicating uneven cash generation.
- Periods of negative Net Interest Income/Expense in some past quarters (e.g., Q3 2023 and Q1 2023), which may indicate periods of margin pressure or financing costs exceeding yield.
- Repayment of Debt remains sizable, with repayments near $193 million in Q2 2025 and $213 million in Q4 2024, adding refinancing risk and impacting cash balances.
- Retained Earnings have been negative throughout, reaching about -$25 million as of Q2 2025, indicating accumulated losses or distributions exceeding profits in the past.
Summary: Bain Capital Specialty Finance exhibits growth in assets and a generally healthy equity base, with recent improved profitability after a challenging start to 2025. The company continues generating strong interest income, albeit with volatility in non-interest income and operating cash flow. Significant debt repayments are ongoing, which requires monitoring for refinancing risk. Investors should watch for continued stabilization in earnings and operating cash to confirm a durable recovery trajectory.
09/12/25 07:19 AM ETAI Generated. May Contain Errors.